期刊文献+

腺病毒介导的CD基因在人胰腺癌细胞中的靶向性表达 被引量:1

Targeting Expression of Cytosine Deaminase Gene by Adenovirus mediated Transfer in Human Pancreatic Carcinoma Cells
暂未订购
导出
摘要 【目的】探讨腺病毒介导的大肠杆菌胞嘧啶脱氨酶 (E .coliCD)基因在胰腺癌细胞中靶向性表达的可能性及其作用。【方法】将含癌胚抗原 (carcinoembryonicantigenCEA)启动子的重组腺病毒感染人胰腺癌SW1990细胞 (CEA+ )、Capan 2细胞 (CEA-)和人宫颈癌Hela细胞 ,观察CD基因在 3种细胞中的表达及细胞对 5 FC的敏感性差异。【结果】腺病毒介导CD基因仅在SW1990细胞中呈专一性表达 ,转导CD基因的SW1990细胞对 5 FC的敏感性明显提高。【结论】含CEA启动子的CD基因疗法可能是胰腺癌靶向性基因治疗的可行途径。 Objective To explore the possibility of the targeting expression of Escherichia coli cytosine deaminase(CD) gene by adenovirus-mediated transfer in human pancreatic carcinoma cells. Methods] Recombinant adenoviruses containing a carcinoembryonic antigen(CEA) promoter were transiently introduced into SW1990、 Capan-2 and Hela cells respectively. These cells were analyzed for gene expression and sensitivity to 5 fluorocytosine(5 FC). Results A specific expression of cytosine deaminase gene by adenovirus-mediated transfer exibited only in SW1990 cells. Transduction of the vector containing CEA promoter cytosine deaminase gene resulted in significant increase of sensitivity of SW1990 cells (CEA producing) to 5 FC. Conclusion These results demonstrate that utilization of the CEA promoter in an adenoviral vector may be a potential approach for targeting gene therapy of pancreatic carcinoma.
出处 《中山医科大学学报》 CSCD 2000年第3期176-178,共3页 Academic Journal of Sun Yat-sen University of Medical Sciences
基金 中山医科大学科研基金资助课题!(97112)
关键词 胰腺肿瘤 腺病毒 CD基因 基因治疗 靶向性表达 pancreatic neoplasms adenoviruses,human cytosine deaminase/gene therapy carcinoembryonic antigen
  • 相关文献

参考文献1

共引文献3

同被引文献6

  • 1Chen C T, Lin J, Li Q, et al. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin[J]. Hum Gene ther, 2000, 11 (14) : 1983.
  • 2O'Relly, M S, Boelm T, Shing Y, et al. Endostatin: an endogeneous inhibitor of angiogenesis and tumor growth[J ]. Cell, 1997, 88(2): 277.
  • 3Boehm T, Folkman J, Brcower T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance[J ]. Nature, 1997,390(6658) :404.
  • 4Hanahan D, Folkman J. Patterns and emerging mechanism of the angiogenic switch during tumorigenesis[J]. Cell, 1996, 86(3): 353.
  • 5Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases[J]. Nat Med, 1995,1(1): 27.
  • 6Crystal R G. The body as a manufacturer of endostatin [J]. Nat Biotechnol, 1999, 17(4): 336.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部